The Effect of FP-025, on Allergen-induced Airway Responses in Mild Eosinophilic House Dust Mite (HDM)-Allergic Asthma.
NCT03858686
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma, COPD
Interventions
DRUG:
FP-025 capsules
DRUG:
Placebo FP-025 capsules
Sponsor
Foresee Pharmaceuticals Co., Ltd.